US CDC advisers to review Moderna, J&J COVID-19 booster shots this month

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Independent advisers to the US Centers for Disease Control and Prevention will meet later this month to make recommendations on booster doses of Moderna Inc and Johnson \u0026 Johnson\u0027s COVID-19 vaccines, the agency said on Friday (Oct 8). The meetings, on Oct 20 to Oct 21, are scheduled a week after a

Independent advisers to the US Centers for Disease Control and Prevention will meet later this month to make recommendations on booster doses of Moderna Inc and Johnson & Johnson's COVID-19 vaccines, the agency said on Friday .

The meetings, on Oct 20 to Oct 21, are scheduled a week after advisers to the US Food and Drug Administration weigh in on the need for booster doses of the two vaccines. The CDC panel, called Advisory Committee on Immunization Practices, will also discuss COVID-19 vaccines for children on Nov 2 and 3, an agency spokesperson said.

The pediatric meetings are also scheduled a week after FDA advisers review the need for Pfizer Inc's COVID-19 vaccine in children aged five to 11. Pfizer on Thursday said the company and its partner BioNTech SE have asked US regulators to authorise emergency use of their COVID-19 vaccine for children ages 5 to 11.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Mental health startup BetterUp raises funds at near US$5 billion valuationBetterUp said on Friday it had raised US$300 million in a late- stage funding round led by Wellington Management, ICONIQ Growth and Lightspeed Venture Partners, bringing the mental health startup's valuation to nearly US$5 billion. The San Francisco-based company, which hired https://www.reuters.com/artic
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »